251 related articles for article (PubMed ID: 28689321)
21. Malignancy risk and false-negative rate of fine needle aspiration cytology in thyroid nodules ≥4.0 cm.
Bestepe N; Ozdemir D; Tam AA; Dellal FD; Kilicarslan A; Parlak O; Ersoy R; Cakir B
Surgery; 2016 Aug; 160(2):405-12. PubMed ID: 27157121
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography.
Frates MC; Benson CB; Doubilet PM; Kunreuther E; Contreras M; Cibas ES; Orcutt J; Moore FD; Larsen PR; Marqusee E; Alexander EK
J Clin Endocrinol Metab; 2006 Sep; 91(9):3411-7. PubMed ID: 16835280
[TBL] [Abstract][Full Text] [Related]
23. Thyroid nodule size and prediction of cancer.
Kamran SC; Marqusee E; Kim MI; Frates MC; Ritner J; Peters H; Benson CB; Doubilet PM; Cibas ES; Barletta J; Cho N; Gawande A; Ruan D; Moore FD; Pou K; Larsen PR; Alexander EK
J Clin Endocrinol Metab; 2013 Feb; 98(2):564-70. PubMed ID: 23275525
[TBL] [Abstract][Full Text] [Related]
24. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
25. Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery.
Mihailescu DV; Schneider AB
J Clin Endocrinol Metab; 2008 Jun; 93(6):2188-93. PubMed ID: 18381575
[TBL] [Abstract][Full Text] [Related]
26. Solitary thyroid nodule: the risk of cancer and the extent of surgical therapy.
Khairy GA
East Afr Med J; 2004 Sep; 81(9):459-62. PubMed ID: 15626055
[TBL] [Abstract][Full Text] [Related]
27. False-negative results with the Bethesda System of reporting thyroid cytopathology: predictors of malignancy in thyroid nodules classified as benign by cytopathologic evaluation.
Richmond BK; Judhan R; Chong B; Ubert A; AbuRahma Z; Mangano W; Thompson S
Am Surg; 2014 Aug; 80(8):811-6. PubMed ID: 25105404
[TBL] [Abstract][Full Text] [Related]
28. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes in patients with non-diagnostic thyroid fine needle aspiration cytology: usefulness of the thyroid core needle biopsy.
Lee SH; Kim MH; Bae JS; Lim DJ; Jung SL; Jung CK
Ann Surg Oncol; 2014 Jun; 21(6):1870-7. PubMed ID: 24526545
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
[TBL] [Abstract][Full Text] [Related]
31. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
32. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
[TBL] [Abstract][Full Text] [Related]
33. Are solitary thyroid nodules more likely to be malignant?
Bouhabel S; Payne RJ; Mlynarek A; Hier M; Caglar D; Tamilia M
J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):119-23. PubMed ID: 22569012
[TBL] [Abstract][Full Text] [Related]
34. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
35. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules.
Alexander EK; Heering JP; Benson CB; Frates MC; Doubilet PM; Cibas ES; Marqusee E
J Clin Endocrinol Metab; 2002 Nov; 87(11):4924-7. PubMed ID: 12414851
[TBL] [Abstract][Full Text] [Related]
36. Restricting ultrasound thyroid fine needle aspiration biopsy by nodule size: which tumors are we missing? A population-based study.
Brito JP; Singh-Ospina N; Gionfriddo MR; Maraka S; Espinosa De Ycaza A; Rodriguez-Gutierrez R; Morris JC; Montori VM; Tuttle RM
Endocrine; 2016 Mar; 51(3):499-505. PubMed ID: 26254791
[TBL] [Abstract][Full Text] [Related]
37. False negative cytology in large thyroid nodules.
Giles WH; Maclellan RA; Gawande AA; Ruan DT; Alexander EK; Moore FD; Cho NL
Ann Surg Oncol; 2015 Jan; 22(1):152-7. PubMed ID: 25074665
[TBL] [Abstract][Full Text] [Related]
38. Is nodule size an independent predictor of thyroid malignancy?
McHenry CR; Huh ES; Machekano RN
Surgery; 2008 Dec; 144(6):1062-8; discussion 1068-9. PubMed ID: 19041019
[TBL] [Abstract][Full Text] [Related]
39. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
40. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
